Evidence map›Paper›PMID 42117016›Full record

ReviewBMJ oncology2026

Foundation models in computational pathology: methods, applications and clinical implications.

Rasoul Sali, Yodit Aschenaki, Raymond Leveillee, Firas Baba, Liya Tessema, Christopher Dixon, Khaireddine Bachhamba, David Y Zhang

Abstract readReview
In one paragraph

Review in BMJ oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rasoul SaliComputational Pathology, Novino AI, Fort Lauderdale, Florida, USA.
Yodit AschenakiComputational Pathology, Novino AI, Fort Lauderdale, Florida, USA.
Raymond LeveilleeDivision of Urology, Department of Surgery, Florida Atlantic University Charles E Schmidt College of Science, Boca Raton, Florida, USA.
Firas BabaComputational Pathology, Novino AI, Fort Lauderdale, Florida, USA.
Liya TessemaComputational Pathology, Novino AI, Fort Lauderdale, Florida, USA.
Christopher DixonDepartment of Urology, Good Samaritan Hospital Medical Center, Suffern, New York, USA.
Khaireddine BachhambaComputational Pathology, Novino AI, Fort Lauderdale, Florida, USA.
David Y ZhangComputational Pathology, Novino AI, Fort Lauderdale, Florida, USA.ORCID https://orcid.org/0009-0007-7682-5198

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The digitisation of histopathology has accelerated the application of artificial intelligence (AI) to cancer diagnosis and precision oncology; however, most deployed AI systems remain narrowly task-specific and difficult to translate across diverse clinical environments. Pathology foundation AI models are emerging as a unifying paradigm, enabling the learning of generalisable representations of tissue morphology through large-scale pre-training and supporting a broad range of downstream tasks. In this narrative review, we examine the development, methodological foundations and current landscape of pathology foundation models in oncological pathology. We outline the evolution and principal trends in the field, classify the major model types and modalities and evaluate their capabilities and advantages in comparison with conventional pathology AI systems. We also examine the transition from foundation models to agentic AI systems and its implications for integrated, workflow-aware pathology practice. In addition, we review relevant regulatory and governance frameworks, with particular attention to requirements for validation, accountability, transparency and oversight.

Indexed as

Neoplasms

Identifiers

PMID42117016
PMCPMC13157769

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.